Potential role for statins in the treatment of chronic HCV infection

被引：4

作者：

Zhu, Qianqian ^{[1
]}

Han, Qunying ^{[1
]}

Liu, Zhengwen ^{[1
]}

机构：

[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Infect Dis, Xian 710061, Shaanxi Provinc, Peoples R China

来源：

FUTURE VIROLOGY | 2013年 / 8卷 / 08期

关键词：

chronic hepatitis C; direct-acting antiviral; host-targeting agent; IFN-; ribavirin; statin; treatment; CHRONIC HEPATITIS-C; VIRUS-RNA REPLICATION; PEGYLATED INTERFERON; COMBINATION THERAPY; ANTIVIRAL EFFICACY; PLUS RIBAVIRIN; GENOTYPE; 1B; OPEN-LABEL; FLUVASTATIN; RESISTANCE;

D O I：

10.2217/fvl.13.70

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：727 / 729

页数：3

共 20 条

[1] Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b [J].

Atsukawa, Masanori ;

Tsubota, Akihito ;

Kondo, Chisa ;

Itokawa, Norio ;

Narahara, Yoshiyuki ;

Nakatsuka, Katsuhisa ;

Hashimoto, Satomi ;

Fukuda, Takeshi ;

Matsushita, Yoko ;

Kidokoro, Hideko ;

Kobayashi, Tamaki ;

Kanazawa, Hidenori ;

Sakamoto, Choitsu .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (01) :51-56

[2] Fluvastatin inhibits hepatitis C replication in humans [J].

Bader, Ted ;

Fazili, Javid ;

Madhoun, Mohammed ;

Aston, Christopher ;

Hughes, Diane ;

Rizvi, Syed ;

Seres, Ken ;

Hasan, Muhammad .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (06) :1383-1389

[3]

Chauvin B, 2013, CLIN PHARMACOKINET, DOI 10. 1007/s40262-013-0075-4

[4] Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development [J].

Delang, Leen ;

Paeshuyse, Jan ;

Vliegen, Inge ;

Leyssen, Pieter ;

Obeid, Susan ;

Durantel, David ;

Zoulim, Fabien ;

de Beeck, Anne Op ;

Neyts, Johan .

HEPATOLOGY, 2009, 50 (01) :6-16

[5] Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C [J].

Gane, Edward J. ;

Stedman, Catherine A. ;

Hyland, Robert H. ;

Ding, Xiao ;

Svarovskaia, Evguenia ;

Symonds, William T. ;

Hindes, Robert G. ;

Berrey, M. Michelle .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (01) :34-44

[6] Hepatitis C virus resistance to protease inhibitors [J].

Halfon, Philippe ;

Locarnini, Stephen .

JOURNAL OF HEPATOLOGY, 2011, 55 (01) :192-206

[7] Different anti-HCV profiles of statins and their potential for combination therapy with interferon [J].

Ikeda, Masanori ;

Abe, Ken-ichi ;

Yamada, Masashi ;

Dansako, Hiromichi ;

Naka, Kazuhito ;

Kato, Nobuyuki .

HEPATOLOGY, 2006, 44 (01) :117-125

[8] Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection [J].

Jacobson, Ira M. ;

McHutchison, John G. ;

Dusheiko, Geoffrey ;

Di Bisceglie, Adrian M. ;

Reddy, K. Rajender ;

Bzowej, Natalie H. ;

Marcellin, Patrick ;

Muir, Andrew J. ;

Ferenci, Peter ;

Flisiak, Robert ;

George, Jacob ;

Rizzetto, Mario ;

Shouval, Daniel ;

Sola, Ricard ;

Terg, Ruben A. ;

Yoshida, Eric M. ;

Adda, Nathalie ;

Bengtsson, Leif ;

Sankoh, Abdul J. ;

Kieffer, Tara L. ;

George, Shelley ;

Kauffman, Robert S. ;

Zeuzem, Stefan .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25) :2405-2416

[9] Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids [J].

Kapadia, SB ;

Chisari, FV .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2561-2566

[10] An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin [J].

Kondo, C. ;

Atsukawa, M. ;

Tsubota, A. ;

Itokawa, N. ;

Fukuda, T. ;

Matsushita, Y. ;

Kidokoro, H. ;

Kobayashi, T. ;

Narahara, Y. ;

Nakatsuka, K. ;

Kanazawa, H. ;

Sakamoto, C. .

JOURNAL OF VIRAL HEPATITIS, 2012, 19 (09) :615-622

← 1 2 →